预测类风湿关节炎疾病活动度评分模型的开发与验证:迈向远程达标治疗
本研究利用鹿特丹早期关节炎队列和RA减停策略试验中612例患者的5802次访视数据,采用LASSO回归开发仅含12个预测因子的模型以预测DAS,并在1554例患者的4404次访视中外部验证。模型判断活动性疾病(DAS>2.4)的AUC-ROC在开发集与内部验证集均为0.89、外部验证集为0.82,判断缓解(DAS<1.6)分别为0.86、0.85和0.82。
要点
- 仅用年龄、性别、病程、VAS总体健康、7项HAQ-DI和VAS疼痛共12个预测因子即可预测DAS。
- 外部验证中判断活动性疾病AUC-ROC为0.82,判断缓解为0.82。
- 该模型支持类风湿关节炎的数字化远程疾病活动度评估。
核心结论
- 结合临床变量与PROM条目的DAS预测模型可准确区分RA疾病活动状态,支持其未来用于远程监测。
研究设计与样本
- 采用鹿特丹早期关节炎队列和RA减停策略试验中612例患者的5802次访视,按1:1随机分为开发集与内部验证集。
- 外部验证使用早期关节炎队列中1554例患者的4404次访视。
- 采用LASSO回归开发模型,纳入年龄、性别、病程、自身抗体状态及各项PROM条目预测DAS。
主要发现
- 最终模型纳入28个预测因子中的12个:年龄、性别、病程、VAS总体健康、7项HAQ-DI条目和VAS疼痛。
- 检测活动性疾病(DAS>2.4)的AUC-ROC在开发集和内部验证集均为0.89,外部验证集为0.82。
- 检测缓解(DAS<1.6)的AUC-ROC在开发集、内部验证集和外部验证集分别为0.86、0.85和0.82。
- 原文报告了不同阈值下的敏感度和特异度。
关键数值与推荐
- 活动性疾病定义为DAS>2.4,缓解定义为DAS<1.6,模型在上述阈值下评估判别能力。
临床怎么用
- 该模型可用于RA患者的数字化远程疾病活动度评估,辅助区分活动性疾病与缓解状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Remote monitoring of disease activity in patients with rheumatoid arthritis (RA) offers a promising solution to increasing healthcare demands. This study aimed to develop and validate a model using selected clinical and patient-reported outcome measure (PROM) items that efficiently and accurately reflect the original disease activity score (DAS). METHODS: Data from 5802 visits of 612 patients with RA from the treatment in the Rotterdam Early Arthritis Cohort and TApering strategies in RA trials were randomly split (1:1) into derivation and internal validation sets. An external validation was performed using 4404 visits from 1554 patients with RA from the Early Arthritis Cohort. A model was developed using Least Absolute Shrinkage and Selection Operator (LASSO) regression that incorporated age, sex, disease duration, autoantibody status, and individual PROM items, including visual analogue scale (VAS) general health, all Health Assessment Questionnaire-Disability Index (HAQ-DI) items, VAS pain, and VAS fatigue, to predict the DAS. The model's ability to detect active disease (DAS >2.4) and remission (DAS <1.6) was evaluated using the area under the receiver operating characteristic curve (AUC-ROC), along with sensitivity and specificity across predefined thresholds. RESULTS: The final model included 12 out of 28 predictors: age, sex, disease duration, VAS general health, 7 HAQ-DI items, and VAS pain. It showed excellent discriminative ability for detecting active disease with AUC-ROC values of 0.89 in both the development and internal validation sets, and 0.82 in the external validation set. For detecting remission, the AUC-ROC values were 0.86, 0.85, and 0.82, respectively. Test characteristics were provided for different thresholds. CONCLUSIONS: The proposed DAS intended for digital remote assessment combines clinical and PROM items and can accurately and efficiently distinguish between disease activity states in RA, supporting its potential use in remote monitoring in the future.
引用
- Looijen AEM, Welsing PMJ, Bergstra SA, et al. Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis. Ann Rheum Dis. 2025. PMID: 41412913. doi:10.1016/j.ard.2025.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。